148 related articles for article (PubMed ID: 2015217)
1. Designing synthetic superagonists of C3a anaphylatoxin.
Ember JA; Johansen NL; Hugli TE
Biochemistry; 1991 Apr; 30(15):3603-12. PubMed ID: 2015217
[TBL] [Abstract][Full Text] [Related]
2. Biochemistry and biology of anaphylatoxins.
Hugli TE
Complement; 1986; 3(3):111-27. PubMed ID: 3542363
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of the anaphylatoxins.
Hugli TE
Springer Semin Immunopathol; 1984; 7(2-3):193-219. PubMed ID: 6387982
[TBL] [Abstract][Full Text] [Related]
4. Reevaluation of the C3a active site using short synthetic C3a analogues.
Köhl J; Casaretto M; Gier M; Karwath G; Gietz C; Bautsch W; Saunders D; Bitter-Suermann D
Eur J Immunol; 1990 Jul; 20(7):1463-8. PubMed ID: 2387312
[TBL] [Abstract][Full Text] [Related]
5. Biologic activity of synthetic analogues of C5a anaphylatoxin.
Ember JA; Sanderson SD; Taylor SM; Kawahara M; Hugli TE
J Immunol; 1992 May; 148(10):3165-73. PubMed ID: 1578141
[TBL] [Abstract][Full Text] [Related]
6. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
7. Role of the second extracellular loop of human C3a receptor in agonist binding and receptor function.
Chao TH; Ember JA; Wang M; Bayon Y; Hugli TE; Ye RD
J Biol Chem; 1999 Apr; 274(14):9721-8. PubMed ID: 10092660
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of an isolated helical capping box in solution by hydrophobic interactions: evidence from the NMR study of bioactive peptides from the C-terminus of human C5a anaphylatoxin.
Ni F; Carpenter KA; Ripoll DR; Sanderson SD; Hugli TE
Biopolymers; 1996 Jan; 38(1):31-41. PubMed ID: 8679942
[TBL] [Abstract][Full Text] [Related]
9. The active site of human C4a anaphylatoxin.
Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
[TBL] [Abstract][Full Text] [Related]
10. The active site of C3a anaphylatoxin.
Caporale LH; Tippett PS; Erickson BW; Hugli TE
J Biol Chem; 1980 Nov; 255(22):10758-63. PubMed ID: 6968751
[TBL] [Abstract][Full Text] [Related]
11. Active site of C3a anaphylatoxin: contributions of the lipophilic and orienting residues.
Unson CG; Erickson BW; Hugli TE
Biochemistry; 1984 Feb; 23(4):585-9. PubMed ID: 6608957
[TBL] [Abstract][Full Text] [Related]
12. Helical conformation at the carboxy-terminal portion of human C3a is required for full activity.
Hoeprich PD; Hugli TE
Biochemistry; 1986 Apr; 25(8):1945-50. PubMed ID: 3486674
[TBL] [Abstract][Full Text] [Related]
13. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.
Bubeck P; Grötzinger J; Winkler M; Köhl J; Wollmer A; Klos A; Bautsch W
Eur J Biochem; 1994 Feb; 219(3):897-904. PubMed ID: 8112341
[TBL] [Abstract][Full Text] [Related]
14. Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.
Hugli TE; Erickson BW
Proc Natl Acad Sci U S A; 1977 May; 74(5):1826-30. PubMed ID: 266705
[TBL] [Abstract][Full Text] [Related]
15. Conformational analysis of COOH-terminal segments of human C3a. Evidence of ordered conformation in an active 21-residue peptide.
Lu ZX; Fok KF; Erickson BW; Hugli TE
J Biol Chem; 1984 Jun; 259(12):7367-70. PubMed ID: 6610676
[TBL] [Abstract][Full Text] [Related]
16. Functional activities of synthetic anaphylatoxic peptides in widely used biological assays.
Kola A; Klos A; Bautsch W; Kretzschmar T; Köhl J
Clin Exp Immunol; 1992 May; 88(2):368-72. PubMed ID: 1572104
[TBL] [Abstract][Full Text] [Related]
17. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.
Fernandez HN; Hugli TE
J Biol Chem; 1978 Oct; 253(19):6955-64. PubMed ID: 690134
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning of two isoforms of the guinea pig C3a anaphylatoxin receptor: alternative splicing in the large extracellular loop.
Fukuoka Y; Ember JA; Hugli TE
J Immunol; 1998 Sep; 161(6):2977-84. PubMed ID: 9743361
[TBL] [Abstract][Full Text] [Related]
19. Synthetic peptides as antagonists of the anaphylatoxin C3a.
Kretzschmar T; Pohl M; Casaretto M; Przewosny M; Bautsch W; Klos A; Saunders D; Köhl J
Eur J Biochem; 1992 Nov; 210(1):185-91. PubMed ID: 1446671
[TBL] [Abstract][Full Text] [Related]
20. Characterization of synthetic C3a analog peptides on human eosinophils in comparison to the native complement component C3a.
Petering H; Köhl J; Weyergraf A; Dulkys Y; Kimmig D; Smolarski R; Kapp A; Elsner J
J Immunol; 2000 Apr; 164(7):3783-9. PubMed ID: 10725738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
